Cross-Checking between ED Physicians Reduces Harm
|
By HospiMedica International staff writers Posted on 08 May 2018 |

Image: A new study suggests a few minutes of consultation can avoid adverse ED events (Photo courtesy of Dreamstime).
A new study suggests that systematic cross-checking between doctors may be a key to reducing the high rate of adverse events in the emergency department (ED).
Researchers at the Sorbonne University (Paris, France), Pitie-Salpetriere Hospital (Paris, France), and other institutions conducted a cluster randomized crossover trial that included a random sample of 1,680 patients attended to in six EDs in France during two 10-day periods. The intervention included systematic cross-checking between ED physicians three times a day, which included a brief presentation of one physician’s case to another, followed by the second physician’s feedback. The main outcome was medical error, defined as either a near miss or a serious adverse event.
The results showed that there were 54 adverse events among 840 patients (6.4%) during the cross-check intervention, compared with 90 adverse events among 840 patients (10.7%) during the control period, a relative reduction of 40%. Most of the reductions occurred in adverse events defined as near misses, with a reduction of 47%. Errors in sepsis management accounted for more than 40% of the preventable serious adverse events. The median duration of cross-checking sessions was nine minutes, during which about seven patients were discussed. The study was published on April 23, 2018, in JAMA Internal Medicine.
“The reduction in preventable serious adverse events with systematic cross-checking did not reach statistical significance; only reductions in near misses did,” explained lead author Yonathan Freund, MD, PhD, of Hôpital Pitié-Salpêtrière. “Whether an adverse event resulted from a misdiagnosis or from the implementation of an inappropriate plan for the correct diagnosis could not be determined decisively. This included sepsis-associated medical errors, which may be particularly relevant, because the most commonly occurring serious adverse events were violations of the surviving sepsis campaign guidelines.”
An adverse event is defined as a preventable or non-preventable injury that was caused by medical management (rather than the underlying disease) and that prolonged hospitalization, produced a disability at the time of discharge, or both. Adverse event also include errors, defined as acts of commission or omission leading to an undesirable outcome or significant potential for such an outcome, and near misses, in which an error was committed, but the patient did not experience clinical harm, either through early detection or sheer luck.
Related Links:
Sorbonne University
Pitie-Salpetriere Hospital
Researchers at the Sorbonne University (Paris, France), Pitie-Salpetriere Hospital (Paris, France), and other institutions conducted a cluster randomized crossover trial that included a random sample of 1,680 patients attended to in six EDs in France during two 10-day periods. The intervention included systematic cross-checking between ED physicians three times a day, which included a brief presentation of one physician’s case to another, followed by the second physician’s feedback. The main outcome was medical error, defined as either a near miss or a serious adverse event.
The results showed that there were 54 adverse events among 840 patients (6.4%) during the cross-check intervention, compared with 90 adverse events among 840 patients (10.7%) during the control period, a relative reduction of 40%. Most of the reductions occurred in adverse events defined as near misses, with a reduction of 47%. Errors in sepsis management accounted for more than 40% of the preventable serious adverse events. The median duration of cross-checking sessions was nine minutes, during which about seven patients were discussed. The study was published on April 23, 2018, in JAMA Internal Medicine.
“The reduction in preventable serious adverse events with systematic cross-checking did not reach statistical significance; only reductions in near misses did,” explained lead author Yonathan Freund, MD, PhD, of Hôpital Pitié-Salpêtrière. “Whether an adverse event resulted from a misdiagnosis or from the implementation of an inappropriate plan for the correct diagnosis could not be determined decisively. This included sepsis-associated medical errors, which may be particularly relevant, because the most commonly occurring serious adverse events were violations of the surviving sepsis campaign guidelines.”
An adverse event is defined as a preventable or non-preventable injury that was caused by medical management (rather than the underlying disease) and that prolonged hospitalization, produced a disability at the time of discharge, or both. Adverse event also include errors, defined as acts of commission or omission leading to an undesirable outcome or significant potential for such an outcome, and near misses, in which an error was committed, but the patient did not experience clinical harm, either through early detection or sheer luck.
Related Links:
Sorbonne University
Pitie-Salpetriere Hospital
Latest Critical Care News
- Smart Pulse Oximetry Supports Earlier Recognition of Arrhythmias and Respiratory Risk
- Wearable Robotic Gait Training Linked to Improved Walking Distance in ALS
- Consumer Smartwatch May Expand Access to Obstructive Sleep Apnea Screening
- Proposed Risk Score Prioritizes Sickest Patients for Heart Transplant
- Wristwatch Sensor Tracks Sodium and Potassium in Sweat in Real Time
- Smart Tear Sensors May Help Detect Shifts in Eye Health Over Time
- Wearable Smart Ring Receives FDA Clearance for Noninvasive Blood Oxygen Monitoring
- AI Tool Combining ECG and Blood Tests Reduces Unnecessary Heart Transplant Biopsies
- Deep Brain Stimulation Window May Matter for Parkinson’s Patients With GBA1 Variants
- Minimally Invasive Ultrasound-Guided Procedure Eases Carpal Tunnel Symptoms
- FDA-Approved App Enables Pulmonary Pressure Monitoring and Medication Guidance in Heart Failure
- Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery
- Standardized Scoring Tool Supports ICU Discharge Decisions
- Battery-Free Wearable Sensor Enables Activity Recognition for Health Monitoring
- New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction
- Noninvasive AI Tool Maps Atrial Cardiomyopathy to Support Ablation Planning
Channels
Artificial Intelligence
view channel
AI Tool Improves Smartphone Detection of Abnormal Pediatric Lung Sounds
Respiratory disease in children remains a major clinical concern worldwide. Abnormal lung sounds can indicate pediatric respiratory illness, but standard auscultation usually requires an in-person examination... Read more
AI Tool Detects Coronary Heart Disease from Face and Tongue Images
Coronary heart disease (CHD) develops when fatty plaques narrow the arteries supplying the heart muscle, restricting blood flow and sometimes first presenting as chest pain, myocardial infarction, or another... Read moreSurgical Techniques
view channel
Targeted Radiotherapy Before Surgery Improves Control of Kidney Cancer Thrombus
Inferior vena cava tumor thrombus occurs when kidney cancer extends into the body’s largest vein, potentially obstructing blood flow, progressing toward the heart, and making surgery more complex.... Read more
New Ultrasonic Surgical Platform Adds Control for Bone and Soft Tissue Removal
Surgical removal of bone and soft tissue requires controlled resection with sufficient power and precision. In demanding neurosurgical procedures, workflow efficiency, ergonomics, and system integration... Read morePatient Care
view channel
AI Platform Personalizes Support Between Visits for Cancer Survivors
Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more
At-Home Neuromodulation Shows Promise in Selected Patients With Hypertension
High blood pressure is a major risk factor for cardiovascular disease, including heart attack and stroke. Many patients receiving treatment for hypertension still remain above recommended blood pressure... Read more
EHR Model Flags High-Risk Periods in Patients with Metastatic Breast Cancer
Determining when patients with metastatic breast cancer are nearing the end of life remains difficult, often leading to intensive interventions with limited benefit. Prognostic uncertainty can delay goals-of-care... Read moreMedical Imaging
view channel
Amyloid and Tau PET Guide Selection and Monitoring of Alzheimer’s Therapy
Alzheimer’s disease is the most common form of dementia and can be difficult to distinguish from other causes of cognitive decline. According to the World Health Organization (WHO), 57 million people were... Read more
MRI Tool Analysis Identifies Vascular Differences in Cerebral Small Vessel Disease
Cerebral small vessel disease (CSVD) involves changes or damage to the brain’s small blood vessels and is associated with stroke and cognitive impairment. Magnetic resonance imaging (MRI) can show cerebral... Read moreHealth IT
view channel
EHR Alerts Support Dosing, Sedation, and Shock Recognition in Cardiac Care
Electronic health record alerts can add to clinician workload when they are poorly targeted. In critical cardiac care, however, delayed decisions can affect treatment timing, sedation exposure, and escalation... Read more
Adaptive Radiation QA Software Gains Validation for NeoArc Treatments
Adaptive radiation therapy allows clinicians to adjust treatment plans to daily anatomical changes such as tumor shrinkage, weight loss, or organ movement, improving precision while limiting exposure to... Read morePoint of Care
view channel
Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes
Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more
Microneedle Patch Enables At-Home Monitoring of Acute Kidney Injury
Kidney disease is often silent in its early stages, making timely detection difficult outside clinical settings. Early biomarkers such as neutrophil gelatinase–associated lipocalin can require blood draws... Read moreBusiness
view channel
Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal
Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Stryker Enters Soft-Tissue Robotics Through Strategic Alliance With CMR Surgical
Stryker (Portage, MI, USA) and CMR Surgical (Cambridge, UK) have announced a strategic alliance centered on the Versius Surgical Robotic portfolio. The agreement includes an approximately USD 400 million... Read more







